Israel Englander Rx Sight, Inc. Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Rx Sight, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 897,846 shares of RXST stock, worth $11.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

897,846

Previous 35,000 2465.27%

Holding current value

$11.2 Million

Previous $1.2 Million 1784.46%

% of portfolio

0.01%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$24.37 - $35.84 $2.67 Million - $3.93 Million	-109,693 Reduced 10.89%	897,846 $22.7 Million
Q4 2024 Feb 14, 2025	BUY	$33.66 - $54.73 $14.8 Million - $24.1 Million	440,071 Added 77.55%	1,007,539 $34.6 Million
Q3 2024 Nov 14, 2024	BUY	$40.78 - $57.04 $15.5 Million - $21.6 Million	378,882 Added 200.91%	567,468 $28 Million
Q2 2024 Aug 14, 2024	SELL	$50.42 - $64.29 $8.38 Million - $10.7 Million	-166,168 Reduced 46.84%	188,586 $11.3 Million
Q1 2024 May 15, 2024	BUY	$35.51 - $57.92 $1.14 Million - $1.86 Million	32,150 Added 9.97%	354,754 $18.3 Million
Q4 2023 Feb 14, 2024	SELL	$20.91 - $40.9 $19 Million - $37.2 Million	-910,749 Reduced 73.84%	322,604 $13 Million
Q2 2023 Aug 14, 2023	BUY	$16.37 - $28.9 $9 Million - $15.9 Million	550,082 Added 80.51%	1,233,353 $35.5 Million
Q1 2023 May 15, 2023	BUY	$12.58 - $16.68 $3.63 Million - $4.81 Million	288,300 Added 72.99%	683,271 $11.4 Million
Q4 2022 Feb 14, 2023	SELL	$9.93 - $14.2 $900,879 - $1.29 Million	-90,723 Reduced 18.68%	394,971 $5 Million
Q3 2022 Nov 14, 2022	SELL	$11.19 - $15.85 $266,031 - $376,817	-23,774 Reduced 4.67%	485,694 $5.83 Million

Others Institutions Holding RXST

# of Institutions

201

Shares Held

34.5M

Call Options Held

269K

Put Options Held

8.5K

View Full List

About RxSight, Inc.

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $344M
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

More about RXST

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account